C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 205/04 (2006.01) C07D 401/04 (2006.01) C07D 401/06 (2006.01) C07D 413/04 (2006.01) C07D 413/06 (2006.01)
Patent
CA 2564501
The present invention is directed to azetidine compounds that inhibit the glycine transporter GlyT1 and which are useful in the treatment of neurological and psychiatric disorders associated with glycinergic or glutamatergic neurotransmission dysfunction and diseases in which the glycine transporter GlyT1 is involved.
La présente invention concerne des composés d'azétidine qui inhibent le transporteur de glycine GlyT1 et lesquels sont utiles dans le traitement de troubles neurologiques et psychiatriques associés à un dysfonctionnement de la neurotransmission glycinergique ou glutamatergique et de maladies dans lesquelles le transporteur de glycine GlyT1 est impliqué.
Hallett David
Lindsley Craig W.
Wolkenberg Scott E.
Merck & Co. Inc.
Merck Sharp & Dohme Limited
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Azetidine glycine transporter inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Azetidine glycine transporter inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azetidine glycine transporter inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2058935